Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected NSCLC
• Intravenous or oral administration of adjuvant vinorelbine/cisplatin appeared equally effective. • Intravenous or oral administration of adjuvant vinorelbine/cisplatin had comparable toxicity profiles. • Equality of effectiveness was significant across all clinico-pathological subgroups.
Gespeichert in:
| Autor*in: |
Sorensen, Steffen Filskov [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2015 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
7 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation - Garrote, Pedro J. ELSEVIER, 2019, journal of the International Association for the Study of Lung Cancer, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:88 ; year:2015 ; number:2 ; pages:167-173 ; extent:7 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.lungcan.2015.02.010 |
|---|
| Katalog-ID: |
ELV012908436 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV012908436 | ||
| 003 | DE-627 | ||
| 005 | 20230623102351.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.lungcan.2015.02.010 |2 doi | |
| 028 | 5 | 2 | |a GBVA2015006000014.pica |
| 035 | |a (DE-627)ELV012908436 | ||
| 035 | |a (ELSEVIER)S0169-5002(15)00117-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 100 | 1 | |a Sorensen, Steffen Filskov |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected NSCLC |
| 264 | 1 | |c 2015 | |
| 300 | |a 7 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Intravenous or oral administration of adjuvant vinorelbine/cisplatin appeared equally effective. • Intravenous or oral administration of adjuvant vinorelbine/cisplatin had comparable toxicity profiles. • Equality of effectiveness was significant across all clinico-pathological subgroups. | ||
| 650 | 7 | |a Oral vinorelbine |2 Elsevier | |
| 650 | 7 | |a Intravenous vinorelbine |2 Elsevier | |
| 650 | 7 | |a Adjuvant chemotherapy |2 Elsevier | |
| 650 | 7 | |a Early-stage |2 Elsevier | |
| 650 | 7 | |a Non-small cell lung cancer |2 Elsevier | |
| 650 | 7 | |a Cisplatin |2 Elsevier | |
| 700 | 1 | |a Carus, Andreas |4 oth | |
| 700 | 1 | |a Meldgaard, Peter |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Garrote, Pedro J. ELSEVIER |t Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |d 2019 |d journal of the International Association for the Study of Lung Cancer |g Amsterdam [u.a.] |w (DE-627)ELV002331438 |
| 773 | 1 | 8 | |g volume:88 |g year:2015 |g number:2 |g pages:167-173 |g extent:7 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.lungcan.2015.02.010 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 951 | |a AR | ||
| 952 | |d 88 |j 2015 |e 2 |h 167-173 |g 7 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
s f s sf sfs |
|---|---|
| matchkey_str |
sorensensteffenfilskovcarusandreasmeldga:2015----:nrvnuooaamnsrtoovnrlienduathmteayihipaia |
| hierarchy_sort_str |
2015 |
| publishDate |
2015 |
| allfields |
10.1016/j.lungcan.2015.02.010 doi GBVA2015006000014.pica (DE-627)ELV012908436 (ELSEVIER)S0169-5002(15)00117-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 Sorensen, Steffen Filskov verfasserin aut Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected NSCLC 2015 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Intravenous or oral administration of adjuvant vinorelbine/cisplatin appeared equally effective. • Intravenous or oral administration of adjuvant vinorelbine/cisplatin had comparable toxicity profiles. • Equality of effectiveness was significant across all clinico-pathological subgroups. Oral vinorelbine Elsevier Intravenous vinorelbine Elsevier Adjuvant chemotherapy Elsevier Early-stage Elsevier Non-small cell lung cancer Elsevier Cisplatin Elsevier Carus, Andreas oth Meldgaard, Peter oth Enthalten in Elsevier Garrote, Pedro J. ELSEVIER Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation 2019 journal of the International Association for the Study of Lung Cancer Amsterdam [u.a.] (DE-627)ELV002331438 volume:88 year:2015 number:2 pages:167-173 extent:7 https://doi.org/10.1016/j.lungcan.2015.02.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 88 2015 2 167-173 7 045F 610 |
| spelling |
10.1016/j.lungcan.2015.02.010 doi GBVA2015006000014.pica (DE-627)ELV012908436 (ELSEVIER)S0169-5002(15)00117-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 Sorensen, Steffen Filskov verfasserin aut Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected NSCLC 2015 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Intravenous or oral administration of adjuvant vinorelbine/cisplatin appeared equally effective. • Intravenous or oral administration of adjuvant vinorelbine/cisplatin had comparable toxicity profiles. • Equality of effectiveness was significant across all clinico-pathological subgroups. Oral vinorelbine Elsevier Intravenous vinorelbine Elsevier Adjuvant chemotherapy Elsevier Early-stage Elsevier Non-small cell lung cancer Elsevier Cisplatin Elsevier Carus, Andreas oth Meldgaard, Peter oth Enthalten in Elsevier Garrote, Pedro J. ELSEVIER Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation 2019 journal of the International Association for the Study of Lung Cancer Amsterdam [u.a.] (DE-627)ELV002331438 volume:88 year:2015 number:2 pages:167-173 extent:7 https://doi.org/10.1016/j.lungcan.2015.02.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 88 2015 2 167-173 7 045F 610 |
| allfields_unstemmed |
10.1016/j.lungcan.2015.02.010 doi GBVA2015006000014.pica (DE-627)ELV012908436 (ELSEVIER)S0169-5002(15)00117-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 Sorensen, Steffen Filskov verfasserin aut Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected NSCLC 2015 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Intravenous or oral administration of adjuvant vinorelbine/cisplatin appeared equally effective. • Intravenous or oral administration of adjuvant vinorelbine/cisplatin had comparable toxicity profiles. • Equality of effectiveness was significant across all clinico-pathological subgroups. Oral vinorelbine Elsevier Intravenous vinorelbine Elsevier Adjuvant chemotherapy Elsevier Early-stage Elsevier Non-small cell lung cancer Elsevier Cisplatin Elsevier Carus, Andreas oth Meldgaard, Peter oth Enthalten in Elsevier Garrote, Pedro J. ELSEVIER Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation 2019 journal of the International Association for the Study of Lung Cancer Amsterdam [u.a.] (DE-627)ELV002331438 volume:88 year:2015 number:2 pages:167-173 extent:7 https://doi.org/10.1016/j.lungcan.2015.02.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 88 2015 2 167-173 7 045F 610 |
| allfieldsGer |
10.1016/j.lungcan.2015.02.010 doi GBVA2015006000014.pica (DE-627)ELV012908436 (ELSEVIER)S0169-5002(15)00117-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 Sorensen, Steffen Filskov verfasserin aut Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected NSCLC 2015 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Intravenous or oral administration of adjuvant vinorelbine/cisplatin appeared equally effective. • Intravenous or oral administration of adjuvant vinorelbine/cisplatin had comparable toxicity profiles. • Equality of effectiveness was significant across all clinico-pathological subgroups. Oral vinorelbine Elsevier Intravenous vinorelbine Elsevier Adjuvant chemotherapy Elsevier Early-stage Elsevier Non-small cell lung cancer Elsevier Cisplatin Elsevier Carus, Andreas oth Meldgaard, Peter oth Enthalten in Elsevier Garrote, Pedro J. ELSEVIER Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation 2019 journal of the International Association for the Study of Lung Cancer Amsterdam [u.a.] (DE-627)ELV002331438 volume:88 year:2015 number:2 pages:167-173 extent:7 https://doi.org/10.1016/j.lungcan.2015.02.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 88 2015 2 167-173 7 045F 610 |
| allfieldsSound |
10.1016/j.lungcan.2015.02.010 doi GBVA2015006000014.pica (DE-627)ELV012908436 (ELSEVIER)S0169-5002(15)00117-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 Sorensen, Steffen Filskov verfasserin aut Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected NSCLC 2015 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Intravenous or oral administration of adjuvant vinorelbine/cisplatin appeared equally effective. • Intravenous or oral administration of adjuvant vinorelbine/cisplatin had comparable toxicity profiles. • Equality of effectiveness was significant across all clinico-pathological subgroups. Oral vinorelbine Elsevier Intravenous vinorelbine Elsevier Adjuvant chemotherapy Elsevier Early-stage Elsevier Non-small cell lung cancer Elsevier Cisplatin Elsevier Carus, Andreas oth Meldgaard, Peter oth Enthalten in Elsevier Garrote, Pedro J. ELSEVIER Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation 2019 journal of the International Association for the Study of Lung Cancer Amsterdam [u.a.] (DE-627)ELV002331438 volume:88 year:2015 number:2 pages:167-173 extent:7 https://doi.org/10.1016/j.lungcan.2015.02.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 88 2015 2 167-173 7 045F 610 |
| language |
English |
| source |
Enthalten in Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation Amsterdam [u.a.] volume:88 year:2015 number:2 pages:167-173 extent:7 |
| sourceStr |
Enthalten in Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation Amsterdam [u.a.] volume:88 year:2015 number:2 pages:167-173 extent:7 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Oral vinorelbine Intravenous vinorelbine Adjuvant chemotherapy Early-stage Non-small cell lung cancer Cisplatin |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |
| authorswithroles_txt_mv |
Sorensen, Steffen Filskov @@aut@@ Carus, Andreas @@oth@@ Meldgaard, Peter @@oth@@ |
| publishDateDaySort_date |
2015-01-01T00:00:00Z |
| hierarchy_top_id |
ELV002331438 |
| dewey-sort |
3610 |
| id |
ELV012908436 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV012908436</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623102351.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.lungcan.2015.02.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015006000014.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV012908436</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0169-5002(15)00117-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sorensen, Steffen Filskov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected NSCLC</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Intravenous or oral administration of adjuvant vinorelbine/cisplatin appeared equally effective. • Intravenous or oral administration of adjuvant vinorelbine/cisplatin had comparable toxicity profiles. • Equality of effectiveness was significant across all clinico-pathological subgroups.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oral vinorelbine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Intravenous vinorelbine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Adjuvant chemotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Early-stage</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Non-small cell lung cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cisplatin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carus, Andreas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Meldgaard, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Garrote, Pedro J. ELSEVIER</subfield><subfield code="t">Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation</subfield><subfield code="d">2019</subfield><subfield code="d">journal of the International Association for the Study of Lung Cancer</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002331438</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:88</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:167-173</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.lungcan.2015.02.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">88</subfield><subfield code="j">2015</subfield><subfield code="e">2</subfield><subfield code="h">167-173</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Sorensen, Steffen Filskov |
| spellingShingle |
Sorensen, Steffen Filskov ddc 610 Elsevier Oral vinorelbine Elsevier Intravenous vinorelbine Elsevier Adjuvant chemotherapy Elsevier Early-stage Elsevier Non-small cell lung cancer Elsevier Cisplatin Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected NSCLC |
| authorStr |
Sorensen, Steffen Filskov |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV002331438 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected NSCLC Oral vinorelbine Elsevier Intravenous vinorelbine Elsevier Adjuvant chemotherapy Elsevier Early-stage Elsevier Non-small cell lung cancer Elsevier Cisplatin Elsevier |
| topic |
ddc 610 Elsevier Oral vinorelbine Elsevier Intravenous vinorelbine Elsevier Adjuvant chemotherapy Elsevier Early-stage Elsevier Non-small cell lung cancer Elsevier Cisplatin |
| topic_unstemmed |
ddc 610 Elsevier Oral vinorelbine Elsevier Intravenous vinorelbine Elsevier Adjuvant chemotherapy Elsevier Early-stage Elsevier Non-small cell lung cancer Elsevier Cisplatin |
| topic_browse |
ddc 610 Elsevier Oral vinorelbine Elsevier Intravenous vinorelbine Elsevier Adjuvant chemotherapy Elsevier Early-stage Elsevier Non-small cell lung cancer Elsevier Cisplatin |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
a c ac p m pm |
| hierarchy_parent_title |
Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |
| hierarchy_parent_id |
ELV002331438 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV002331438 |
| title |
Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected NSCLC |
| ctrlnum |
(DE-627)ELV012908436 (ELSEVIER)S0169-5002(15)00117-8 |
| title_full |
Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected NSCLC |
| author_sort |
Sorensen, Steffen Filskov |
| journal |
Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |
| journalStr |
Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2015 |
| contenttype_str_mv |
zzz |
| container_start_page |
167 |
| author_browse |
Sorensen, Steffen Filskov |
| container_volume |
88 |
| physical |
7 |
| class |
610 610 DE-600 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Sorensen, Steffen Filskov |
| doi_str_mv |
10.1016/j.lungcan.2015.02.010 |
| dewey-full |
610 |
| title_sort |
intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected nsclc |
| title_auth |
Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected NSCLC |
| abstract |
• Intravenous or oral administration of adjuvant vinorelbine/cisplatin appeared equally effective. • Intravenous or oral administration of adjuvant vinorelbine/cisplatin had comparable toxicity profiles. • Equality of effectiveness was significant across all clinico-pathological subgroups. |
| abstractGer |
• Intravenous or oral administration of adjuvant vinorelbine/cisplatin appeared equally effective. • Intravenous or oral administration of adjuvant vinorelbine/cisplatin had comparable toxicity profiles. • Equality of effectiveness was significant across all clinico-pathological subgroups. |
| abstract_unstemmed |
• Intravenous or oral administration of adjuvant vinorelbine/cisplatin appeared equally effective. • Intravenous or oral administration of adjuvant vinorelbine/cisplatin had comparable toxicity profiles. • Equality of effectiveness was significant across all clinico-pathological subgroups. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| container_issue |
2 |
| title_short |
Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected NSCLC |
| url |
https://doi.org/10.1016/j.lungcan.2015.02.010 |
| remote_bool |
true |
| author2 |
Carus, Andreas Meldgaard, Peter |
| author2Str |
Carus, Andreas Meldgaard, Peter |
| ppnlink |
ELV002331438 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth |
| doi_str |
10.1016/j.lungcan.2015.02.010 |
| up_date |
2024-07-06T17:29:08.675Z |
| _version_ |
1803851607494885376 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV012908436</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623102351.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.lungcan.2015.02.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015006000014.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV012908436</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0169-5002(15)00117-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sorensen, Steffen Filskov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected NSCLC</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Intravenous or oral administration of adjuvant vinorelbine/cisplatin appeared equally effective. • Intravenous or oral administration of adjuvant vinorelbine/cisplatin had comparable toxicity profiles. • Equality of effectiveness was significant across all clinico-pathological subgroups.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oral vinorelbine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Intravenous vinorelbine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Adjuvant chemotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Early-stage</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Non-small cell lung cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cisplatin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carus, Andreas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Meldgaard, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Garrote, Pedro J. ELSEVIER</subfield><subfield code="t">Extrinsic factors rather than seed traits mediate strong spatial variation in seed predation</subfield><subfield code="d">2019</subfield><subfield code="d">journal of the International Association for the Study of Lung Cancer</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002331438</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:88</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:167-173</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.lungcan.2015.02.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">88</subfield><subfield code="j">2015</subfield><subfield code="e">2</subfield><subfield code="h">167-173</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.3999157 |